<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Baird Medical Investment Holdings Limited — News on 6ix</title>
<link>https://6ix.com/company/baird-medical-investment-holdings-limited</link>
<description>Latest news and press releases for Baird Medical Investment Holdings Limited on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 29 Apr 2026 12:30:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/baird-medical-investment-holdings-limited" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68354bd678dffbe2df0e5431.webp</url>
<title>Baird Medical Investment Holdings Limited</title>
<link>https://6ix.com/company/baird-medical-investment-holdings-limited</link>
</image>
<item>
<title>Baird Medical Reports Full Year 2025 Financial Results and Provides Corporate Update</title>
<link>https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-reports-full-year-2025-financial-results-and-provides-corporate-update</link>
<guid isPermaLink="true">https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-reports-full-year-2025-financial-results-and-provides-corporate-update</guid>
<pubDate>Wed, 29 Apr 2026 12:30:00 GMT</pubDate>
<description>Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced its financial results for the full year ended December 31, 2025 and provided an update on key strategic and operational initiatives.</description>
</item>
<item>
<title>Baird Medical Advances Clinical Education with Expert-Led Workshops in Indonesia</title>
<link>https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-advances-clinical-education-with-expert-led-workshops-in-indonesia</link>
<guid isPermaLink="true">https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-advances-clinical-education-with-expert-led-workshops-in-indonesia</guid>
<pubDate>Mon, 16 Mar 2026 04:00:00 GMT</pubDate>
<description>NEW YORK, March 16, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in</description>
</item>
<item>
<title>Baird Medical Expands Global Reach with Regulatory Clearance in Argentina</title>
<link>https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-expands-global-reach-with-regulatory-clearance-in-argentina-8</link>
<guid isPermaLink="true">https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-expands-global-reach-with-regulatory-clearance-in-argentina-8</guid>
<pubDate>Thu, 12 Mar 2026 04:00:00 GMT</pubDate>
<description>NEW YORK, March 12, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in</description>
</item>
<item>
<title>Baird Medical Accelerates U.S. Expansion in Interventional Thyroidology at NASIT 2026</title>
<link>https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-accelerates-us-expansion-in-interventional-thyroidology-at-nasit-2026</link>
<guid isPermaLink="true">https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-accelerates-us-expansion-in-interventional-thyroidology-at-nasit-2026</guid>
<pubDate>Mon, 09 Mar 2026 04:00:00 GMT</pubDate>
<description>NEW YORK, March 9, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally</description>
</item>
<item>
<title>Baird Medical Accelerates Global Registration of AI-Driven Surgical Software</title>
<link>https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-accelerates-global-registration-of-ai-driven-surgical-software</link>
<guid isPermaLink="true">https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-accelerates-global-registration-of-ai-driven-surgical-software</guid>
<pubDate>Wed, 04 Mar 2026 13:30:00 GMT</pubDate>
<description>Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the successful completion of development for its cross-platform surgical software, officially commencing the registration process in the United States, the European Union, and China.</description>
</item>
<item>
<title>Baird Medical Accelerates U.S. Expansion at NASOIE 2026</title>
<link>https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-accelerates-us-expansion-at-nasoie-2026</link>
<guid isPermaLink="true">https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-accelerates-us-expansion-at-nasoie-2026</guid>
<pubDate>Mon, 02 Mar 2026 13:30:00 GMT</pubDate>
<description>Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced its participation at the 2026 North American Society of Interventional Endocrinologists (NASOIE) Annual Meeting in Miami, Florida. Building on successful engagements at previous NASOIE gatherings, this initiative reinforces the Company's enduring commitment to physician education and advances its strategy to expand pa</description>
</item>
<item>
<title>Baird Medical Accelerates U.S. Expansion in Interventional Thyroidology</title>
<link>https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-accelerates-us-expansion-in-interventional-thyroidology</link>
<guid isPermaLink="true">https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-accelerates-us-expansion-in-interventional-thyroidology</guid>
<pubDate>Wed, 25 Feb 2026 13:30:00 GMT</pubDate>
<description>Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across the United States. This momentum directly supports the Company's strategy to accelerate global growth and expand patient access to advanced, minimally invasive therapies.</description>
</item>
<item>
<title>Baird Medical to Showcase Minimally Invasive Thyroid Solutions at Upcoming US Clinical Conferences</title>
<link>https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-to-showcase-minimally-invasive-thyroid-solutions-at-upcoming-us-clinical-conferences</link>
<guid isPermaLink="true">https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-to-showcase-minimally-invasive-thyroid-solutions-at-upcoming-us-clinical-conferences</guid>
<pubDate>Thu, 19 Feb 2026 13:30:00 GMT</pubDate>
<description>Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced its participation for three major clinical conferences this quarter. These events are pivotal to the company's expansion, providing U.S. clinicians direct access to its innovative needle-based therapies for thyroid conditions.</description>
</item>
<item>
<title>Baird Medical Drives U.S. Market Penetration with Commercial Launch at Bakersfield Memorial Hospital</title>
<link>https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-drives-u-market-133000346</link>
<guid isPermaLink="true">https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-drives-u-market-133000346</guid>
<pubDate>Wed, 11 Feb 2026 13:30:00 GMT</pubDate>
<description>Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the strategic commercial deployment of its technology at Bakersfield Memorial Hospital in California. This launch represents the first ablation case for Benign Thyroid Tumor (or "of its kind") in the vital central California hub of the San Joaquin Valley. This development reinforces Baird Medical's commitment to accel</description>
</item>
<item>
<title>Baird Medical Accelerates Global Commercial Roadmap with Strategic Clinical Education Initiatives in the U.S. and Japan</title>
<link>https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-accelerates-global-commercial-133000571</link>
<guid isPermaLink="true">https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-accelerates-global-commercial-133000571</guid>
<pubDate>Mon, 09 Feb 2026 13:30:00 GMT</pubDate>
<description>Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the execution of premier clinical education programs in the United States and Japan. These strategic engagements reinforce Baird Medical's market leadership and accelerate its global expansion by establishing standardized clinical excellence for interventional thyroidology.</description>
</item>
<item>
<title>Baird Medical Successfully Concludes Gynecology Microwave Ablation Masterclass</title>
<link>https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-successfully-concludes-gynecology-133000369</link>
<guid isPermaLink="true">https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-successfully-concludes-gynecology-133000369</guid>
<pubDate>Wed, 28 Jan 2026 13:30:00 GMT</pubDate>
<description>Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the successful conclusion of its Gynecological Microwave Ablation Masterclass in Shanghai. Led by Dr. Xiaoming Gong of Weheal, the program offered a rigorous curriculum designed to advance procedural expertise in the treatment of benign gynecological conditions using the Company's proprietary technology.</description>
</item>
<item>
<title>Baird Medical Accelerates Global Commercial Roadmap through Strategic Partnership with Stonewood Key Capital</title>
<link>https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-accelerates-global-commercial-133000091</link>
<guid isPermaLink="true">https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-accelerates-global-commercial-133000091</guid>
<pubDate>Mon, 26 Jan 2026 13:30:00 GMT</pubDate>
<description>Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced a strategic partnership with Stonewood Key Capital, a wholly-owned comprehensive investment management enterprise from New Zealand. This collaboration positions the Hainan Free Trade Port as a pivotal hub for the Company's cross-border operations and supply chain, enabling more efficient capital allocation to accelera</description>
</item>
<item>
<title>Baird Medical Highlights Strategic Engagement at 2026 J.P. Morgan Healthcare Conference</title>
<link>https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-highlights-strategic-engagement-133000770</link>
<guid isPermaLink="true">https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-highlights-strategic-engagement-133000770</guid>
<pubDate>Tue, 20 Jan 2026 13:30:00 GMT</pubDate>
<description>Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced its successful participation in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco.</description>
</item>
<item>
<title>Baird Medical Secures Regulatory Approvals in Pakistan and Vietnam</title>
<link>https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-secures-regulatory-approvals-133000152</link>
<guid isPermaLink="true">https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-secures-regulatory-approvals-133000152</guid>
<pubDate>Wed, 07 Jan 2026 13:30:00 GMT</pubDate>
<description>Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in Microwave Ablation (MWA) technology, today announced it has reached key regulatory milestones with official product registrations from both the Medical Device Board (MDB) of Pakistan and the Ministry of Health of Vietnam.</description>
</item>
<item>
<title>Baird Medical Establishes U.S. Manufacturing Base to Accelerate Global Expansion and Future R&D</title>
<link>https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-establishes-u-manufacturing-133000541</link>
<guid isPermaLink="true">https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-establishes-u-manufacturing-133000541</guid>
<pubDate>Wed, 17 Dec 2025 13:30:00 GMT</pubDate>
<description>Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in Microwave Ablation (MWA) technology, today announced the establishment of a dedicated manufacturing base in the United States. This development marks a pivotal step in Baird Medical's transition from a specialized exporter to a comprehensive global medical technology enterprise.</description>
</item>
<item>
<title>Baird-Sponsored Microwave Ablation Training Enhances Thyroid Treatment Capabilities for Leading Arizona Surgeon</title>
<link>https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-sponsored-microwave-ablation-training-enhances-thyroid-treatment-capabilities-for-leading-arizona-surgeon</link>
<guid isPermaLink="true">https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-sponsored-microwave-ablation-training-enhances-thyroid-treatment-capabilities-for-leading-arizona-surgeon</guid>
<pubDate>Mon, 08 Dec 2025 05:00:00 GMT</pubDate>
<description>NEW YORK, Dec. 8, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in Microwave</description>
</item>
<item>
<title>Baird Medical Appoints Mark Saxton as U.S. CEO; Taps Veteran from NeuroPace, Smith + Nephew, and Covidien to Lead Commercial Expansion</title>
<link>https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-appoints-mark-saxton-133000037</link>
<guid isPermaLink="true">https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-appoints-mark-saxton-133000037</guid>
<pubDate>Wed, 03 Dec 2025 13:30:00 GMT</pubDate>
<description>Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the appointment of Mark Saxton as Chief Executive Officer of its U.S. subsidiary.</description>
</item>
<item>
<title>Baird Medical Enters Egyptian Market with First Successful Bone Tumor Ablation</title>
<link>https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-enters-egyptian-market-133000455</link>
<guid isPermaLink="true">https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-enters-egyptian-market-133000455</guid>
<pubDate>Mon, 03 Nov 2025 13:30:00 GMT</pubDate>
<description>Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced its official launch into the Egyptian market with the successful completion of its first procedure at the prestigious Ain Shams Specialized Hospital.</description>
</item>
<item>
<title>Baird Medical's MWA System Achieves Successful Medicare Reimbursement at Prominent New York Practice</title>
<link>https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medicals-mwa-system-achieves-123000717</link>
<guid isPermaLink="true">https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medicals-mwa-system-achieves-123000717</guid>
<pubDate>Mon, 27 Oct 2025 12:30:00 GMT</pubDate>
<description>Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced the clinical adoption of its MWA system at Elk Medical, a prominent private endocrinology practice in Brooklyn, New York.</description>
</item>
<item>
<title>Baird Medical Announces First Successful Liver Tumor Ablation in Bangladesh</title>
<link>https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-announces-first-successful-123000267</link>
<guid isPermaLink="true">https://6ix.com/company/baird-medical-investment-holdings-limited/news/baird-medical-announces-first-successful-123000267</guid>
<pubDate>Thu, 23 Oct 2025 12:30:00 GMT</pubDate>
<description>Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced the successful completion of its first MWA procedure in Bangladesh. The landmark treatment was performed at USB Hospital in Uttara, Dhaka, marking a significant step forward in the availability of cutting-edge, non-surgical cancer therapies in the region.</description>
</item>
</channel>
</rss>